SHARE-BASED COMPENSATION (Tables)

6 Months Ended

Apr. 28, 2024

The table below presents information on our share-based compensation expenses for the three and six-month periods ended April 28, 2024 and April 30, 2023.

	Three Months Ended				Six Months Ended
	April 28, 2024		April 30, 2023		April 28, 2024		April 30, 2023
Expense reported in:
Cost of goods sold	$	669	$	288	$	1,263	$	570
Selling, general, and administrative		2,987		1,531		4,737		2,908
Research and development		270		190		499		352
Total expense incurred	$	3,926	$	2,009	$	6,499	$	3,830

Expense by award type:
Restricted stock awards	$	3,926	$	1,974	$	6,499	$	3,738
Stock options		-		-		-		1
Employee stock purchase plan		-		35		-		91
Total expense incurred	$	3,926	$	2,009	$	6,499	$	3,830

Income tax benefits of share-based compensation	$	323	$	207	$	421	$	361
Share-based compensation cost capitalized	$	-	$	-	$	-	$	-

Restricted Stock Awards Activity

The table below presents information on our restricted stock awards for the three and six-month periods ended April 28, 2024 and April 30, 2023.

	Three Months Ended				Six Months Ended
	April 28, 2024		April 30, 2023		April 28, 2024		April 30, 2023
Number of shares granted in period		-		-		825,050		786,500
Weighted-average grant-date fair value of awards (in dollars per share)	$	-	$	-	$	29.77	$	16.77
Compensation cost not yet recognized	$	28,695	$	16,419	$	28,695	$	16,419
Weighted-average amortization period for cost not yet recognized (in years)		3.1		3.0		3.1		3.0
Shares outstanding at balance sheet date		1,560,540		1,328,572		1,560,540		1,328,572

Stock Options Activity

The table below presents information on our stock options for three and six-month periods ended April 28, 2024 and April 30, 2023.

	Three Months Ended				Six Months Ended
	April 28, 2024		April 30, 2023		April 28, 2024		April 30, 2023
Number of options granted in period		-		-		-		-
Cash received from option exercised	$	119	$	20	$	1,055	$	583
Compensation cost not yet recognized	$	-	$	-	$	-	$	-
Weighted-average amortization period for cost not yet recognized (in years)		-		-		-		-

Information on Outstanding and Exercisable Option

Information on outstanding and exercisable option awards as of April 28, 2024, is presented below.

Options		Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Life (in years)				Aggregate Intrinsic Value
Outstanding and exercisable at April 28, 2024			360,125			$	10.33				2.34			$	6,466